New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 16, 2014
09:14 EDTTGTXTG Therapeutics price target raised to $20 from $15 at Roth Capital
Roth Capital increased its price target on TG Therapeutics after the company announced data for its TG-1101 & ibrutinib combination in r/r CLL or MCL. The firm was quite impressed by the data and reiterates a Focus Pick rating on the shares.
News For TGTX From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
November 11, 2014
13:14 EDTTGTXTG Therapeutics Phase 3 trial highly likely to succed, says Brean Capital
Subscribe for More Information
November 10, 2014
16:26 EDTTGTXTG Therapeutics reports Q3 EPS with items (51c), consensus (32c)
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use